LU75229A1 - - Google Patents

Info

Publication number
LU75229A1
LU75229A1 LU75229A LU75229A LU75229A1 LU 75229 A1 LU75229 A1 LU 75229A1 LU 75229 A LU75229 A LU 75229A LU 75229 A LU75229 A LU 75229A LU 75229 A1 LU75229 A1 LU 75229A1
Authority
LU
Luxembourg
Application number
LU75229A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU75229A1 publication Critical patent/LU75229A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU75229A 1975-06-25 1976-06-24 LU75229A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528879 DE2528879A1 (de) 1975-06-25 1975-06-25 11 beta-fluor-androstene

Publications (1)

Publication Number Publication Date
LU75229A1 true LU75229A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-02-18

Family

ID=5950147

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75229A LU75229A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-06-25 1976-06-24

Country Status (8)

Country Link
JP (1) JPS523050A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE843437A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD124988A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2528879A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK252276A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2316958A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU75229A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7606822A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439487A (en) * 1982-12-17 1984-03-27 E. I. Du Pont De Nemours & Company Polyester/nylon bicomponent flament

Also Published As

Publication number Publication date
DK252276A (da) 1976-12-26
JPS523050A (en) 1977-01-11
DE2528879A1 (de) 1977-01-13
DD124988A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-03-23
FR2316958A1 (fr) 1977-02-04
BE843437A (fr) 1976-12-27
NL7606822A (nl) 1976-12-28

Similar Documents

Publication Publication Date Title
FR2318794B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU170252B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5523377Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5429281B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5183445A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5442708Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5230405Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5245710U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5628451Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5331500Y1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS51136932U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS51146539U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS51151124U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG22941A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH584620A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU75229A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH603263A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD122695A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH610757A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH610715A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH610314A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH610173A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG22617A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG22869A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH602135A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)